Business
Why did the Exopharm (ASX:EX1) share price surge 12% today?
The Exopharm Ltd (ASX: EX1) share price rocketed today after the company announced positive clinical trial results for its regenerative medical product, Plexaris.
At market close, the Exopharm share price is up by 12.93% today to 65 cents per share.
Exopharm is a biopharmaceutical company focused on developing regenerative medicine. It’s currently investigating the therapeutic potential of two products, Plexaris and Cevaris, in treating osteoarthritis.
The company was undergoing clinical trials to see if the medicine can restore arthritic cell tissue in rats. These clinical trials showed that the drugs had no adverse affects and were safe to trial on humans, however they also showed that drugs’ efficacy was limited to milder…
-
Noosa News22 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged
-
General15 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General19 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
General8 hours agoThe one tweak that could grow your super by $200,000